Medicine and Dentistry
Regulatory T Cell
100%
Allograft
100%
T Cell
85%
Hepatocyte
60%
Intrajejunal Drug Administration
48%
Graft Survival
36%
Immunological Tolerance
36%
Cyclosporine
36%
Allotransplantation
28%
Oral Drug Administration
24%
Low Drug Dose
24%
Alloantigen
24%
Toxicity
12%
Side Effect
12%
Whole Body Radiation
12%
Larynx
12%
Neck
12%
Interleukin 10
12%
Skin Flap
12%
Transforming Growth Factor Beta
12%
Interleukin 4
12%
Inguinal Flap
12%
Histocompatibility Complex
12%
Mixed Lymphocyte Reaction
12%
Back
12%
Heart Transplantation
12%
Subcutaneous Tissue
12%
Chronic Graft Rejection
12%
Inbred Strain
12%
Gastrojejunostomy
12%
Cell Population
12%
T Cell Activation
12%
Experimental Autoimmune Disease
12%
Immune Response
12%
In Vitro
12%
Immunosuppressive Treatment
12%
Combination Therapy
12%
Chimera
12%
Immunology and Microbiology
Splenocyte
100%
Regulatory T Cell
100%
CD4
100%
CD25
100%
T Cell
61%
Lewis Rat
61%
Allograft
50%
Immune Tolerance
26%
Ciclosporin
26%
Allotransplantation
20%
Allotransplantation
20%
Low Drug Dose
17%
Alloantigen
17%
Brown Norway Rat
17%
Immunosuppressive Therapy
8%
T Cell Activation
8%
Immune Response
8%
Chimera
8%
August Copenhagen Irish Rat
8%
Neck
8%
Histocompatibility Complex
8%
Rat Model
8%
Back
8%
Transforming Growth Factor Beta
8%
Mixed Lymphocyte Reaction
8%
Cell Population
8%
Experimental Autoimmune Disease
8%
Chronic Graft Rejection
8%
Interleukin 4
8%
Interleukin 10
8%
Inbred Strain
8%
Subcutaneous Tissue
5%
Pharmacology, Toxicology and Pharmaceutical Science
Lewis Rat
100%
Ciclosporin
42%
Brown Norway Rat
28%
Alloantigen
28%
Route of Administration
14%
Rat Model
14%
Combination Therapy
14%
Toxicity
14%
Side Effect
14%
Interleukin 10
14%
Transforming Growth Factor Beta
14%
Immunosuppressive Agent
14%
Interleukin 4
14%
August Copenhagen Irish Rat
14%
Chronic Graft Rejection
14%
Experimental Autoimmune Disease
14%